Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBF.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-1427.97China
B.1.177.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-1427.97China
B.1.1.445ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-1427.97China
B.1.1.412EWon-ECACACAATCGATGCGCAGTA20502636526346R-1441.38South Korea
B.1.1.348SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-1450.82Japan
KP.3.1.3ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1453.47Japan
GS.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-1463.38Germany
FL.20ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-1463.38Germany
B.1.1.112ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-1474.25Japan
B.1.36.22ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-1474.95Japan
GN.4ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-1474.95Japan
B.1.39NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1480.18South Korea
B.1.287SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-1489.66Japan
B.1.1.74NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-1491.05US
B.1.1.53ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-1491.08France
BA.2.75.1ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-1491.08France
BA.2.75.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-1505.13China
BA.2.23ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-1517.51Japan
BA.5.5.1ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-1517.51Japan
BN.1.3.12ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-1517.51Japan
BA.2.9ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-1517.51Japan
BN.1.3.1ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-1517.51Japan
BQ.1.1ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-1517.51Japan
BF.7.6ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-1517.51Japan
B.45ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-1517.51Japan
XBB.1.11.1ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-1517.51Japan
XBB.1.5.78ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-1517.51Japan
BA.1.21ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-1517.51Japan
B.1.177.35ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-1517.51Japan
XCH.1SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-1524.99Japan
XCHSNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-1524.99Japan
JG.3.3SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-1524.99Japan
GK.1.10SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-1524.99Japan
FT.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-1540.71France
C.13NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-1544.5China
AY.91.1 (Delta)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-1544.5China
B.1.1.59NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-1544.5China
B.1.232NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-1544.5China
B.1.160.25NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-1544.5China
B.1.39NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-1544.5China
B.1.274NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-1544.5China
B.1.515NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-1544.5China
B.1.258.23NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-1544.5China
AJ.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-1544.5China
BA.2.75.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-1547.71Singapore
BE.1.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-1549.93US
BQ.1.18NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-1549.93US
B.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1575.86US
B.50NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1575.86US
N.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1575.86US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used